FDA GRAS and FEMA GRAS achieved.
Rancho Santa Margarita, Calif., (Oct. 28, 2020) – As clean-label zero-calorie natural sweeteners continue to be attractive to consumers, SweeGen announced the expansion of its natural sweetener portfolio with the commercial production of Bestevia® Reb I, a next generation high-purity stevia sweetener and flavor unique to SweeGen.
Reb I expands SweeGen’s toolbox for tackling the challenges of reducing sugar and delivering sweet taste solutions to food and beverage manufacturers. This newest edition to SweeGen’s natural sweetener portfolio works well in product applications across the spectrum, ranging from dairy, beverages, nutritional bars, confectionery to savory.
“Reb I is yet another unique and diverse flavor that we can use in our creative building block approach to sugar reduction for creating consumer-preferred sugar-reduced food and beverage products, and delivering winning solutions to our clients,” said Chief of Global Flavor Application Technology, Shari Mahon.
Reb I imparts a clean taste profile and sugar-like sweetness and complements SweeGen’s application technology. It is a versatile sweetener which can be used at various levels of sugar reduction to drive unique taste profiles.
Reb I is produced by a patented bioconversion technology, starting with the stevia leaf. This process was developed by Conagen, a biotech innovator of sustainable ingredients. SweeGen’s entire proprietary portfolio of next generation, natural Bestevia stevia sweeteners are produced with Conagen’s bioconversion technology, and are classified as next generation non-GMO, high-purity, and clean tasting. The Bestevia portfolio includes Rebs B, D, E and M, and now Reb I. These Rebs translate to highly-relevant clean-label, sustainable, natural sweeteners that consumers seek.
More than 66% of consumers prefer to see natural sweeteners rather than artificial on labels. This trend drives brands to search for solutions in the natural sweetener and plant-based spaces which now includes Bestevia Reb I.
SweeGen has already received the FDA Generally Regarded As Safe (GRAS) no objection letter, and acceptance from The Flavor and Extract Manufacturers Association (FEMA). Global regulatory approval is underway.
“Conagen is happy to support the successful commercialization of Reb I as the latest offering from our pipeline of non-caloric sweeteners. We are looking forward to additional unique and novel stevia sweeteners for providing greater flexibility and options to food and beverage manufacturers,” said Conagen’s VP of Innovation, Dr. Casey Lippmeier.
SweeGen provides sweet taste solutions for global food and beverage manufacturers.
We are on a mission to reduce the sugar and artificial sweeteners in our global diet. Partnering with customers, we create delicious zero-sugar products that consumers love. With the best next generation stevia sweeteners in our portfolio such as Bestevia® Rebs B, D, E, I and M, along with our deep knowledge of flavor modulators and texturants, SweeGen delivers market-leading solutions that customers want and consumers prefer.
For more information please contact email@example.com and visit SweeGen’s website, www.sweegen.com.
Conagen is making the impossible possible. Our scientists and engineers are bettering humankind and the world by employing advanced synthetic biology tools for the bioproduction of high-value ingredients for food, nutrition, flavor and fragrance, pharmaceutical, and renewable materials industries. www.conagen.com
Cautionary Statement Concerning Forward-Looking Statements
This press release contains forward looking statements, including, among other statements, statements regarding the future prospects for Rebs, B, D, E, I and M stevia leaf sweeteners. These statements are based on current expectations, but are subject to certain risks and uncertainties, many of which are difficult to predict and are beyond the control of SweeGen, Inc.
Relevant risks and uncertainties include those referenced in the historic filings of SweeGen, Inc. with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. SweeGen, Inc. assumes no obligation to update any forward-looking statements as a result of new information or future events or developments.